FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942262171> ?p ?o ?g. }

• W2942262171 endingPage "1672" @default.
• W2942262171 startingPage "1665" @default.
• W2942262171 abstract "Current treatments for Mycobacterium tuberculosis infections require long and complicated regimens that can lead to patient non-compliance, increasing incidences of antibiotic-resistant strains, and lack of efficacy against latent stages of disease. Thus, new therapeutics are needed to improve tuberculosis standard of care. One strategy is to target protein homeostasis pathways by inhibiting molecular chaperones such as GroEL/ES (HSP60/10) chaperonin systems. M. tuberculosis has two GroEL homologs: GroEL1 is not essential but is important for cytokine-dependent granuloma formation, while GroEL2 is essential for survival and likely functions as the canonical housekeeping chaperonin for folding proteins. Another strategy is to target the protein tyrosine phosphatase B (PtpB) virulence factor that M. tuberculosis secretes into host cells to help evade immune responses. In the present study, we have identified a series of GroEL/ES inhibitors that inhibit M. tuberculosis growth in liquid culture and biochemical function of PtpB in vitro. With further optimization, such dual-targeting GroEL/ES and PtpB inhibitors could be effective against all stages of tuberculosis – actively replicating bacteria, bacteria evading host cell immune responses, and granuloma formation in latent disease – which would be a significant advance to augment current therapeutics that primarily target actively replicating bacteria." @default.
• W2942262171 created "2019-05-03" @default.
• W2942262171 creator A5002042871 @default.
• W2942262171 creator A5020704398 @default.
• W2942262171 creator A5024562621 @default.
• W2942262171 creator A5036429812 @default.
• W2942262171 creator A5036871501 @default.
• W2942262171 creator A5038951690 @default.
• W2942262171 creator A5041727371 @default.
• W2942262171 creator A5057562012 @default.
• W2942262171 creator A5060147350 @default.
• W2942262171 creator A5074925440 @default.
• W2942262171 creator A5083715536 @default.
• W2942262171 creator A5084165762 @default.
• W2942262171 creator A5089233697 @default.
• W2942262171 date "2019-07-01" @default.
• W2942262171 modified "2023-10-15" @default.
• W2942262171 title "Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections" @default.
• W2942262171 cites W1520392406 @default.
• W2942262171 cites W1540311954 @default.
• W2942262171 cites W1971108880 @default.
• W2942262171 cites W1981676889 @default.
• W2942262171 cites W1988375443 @default.
• W2942262171 cites W1994444436 @default.
• W2942262171 cites W1995412010 @default.
• W2942262171 cites W2001010604 @default.
• W2942262171 cites W2029086579 @default.
• W2942262171 cites W2042484271 @default.
• W2942262171 cites W2050430115 @default.
• W2942262171 cites W2054607729 @default.
• W2942262171 cites W2055981208 @default.
• W2942262171 cites W2065638048 @default.
• W2942262171 cites W2068010687 @default.
• W2942262171 cites W2069660233 @default.
• W2942262171 cites W2076272826 @default.
• W2942262171 cites W2077247303 @default.
• W2942262171 cites W2094670023 @default.
• W2942262171 cites W2095231417 @default.
• W2942262171 cites W2095318368 @default.
• W2942262171 cites W2096966529 @default.
• W2942262171 cites W2098766459 @default.
• W2942262171 cites W2101740624 @default.
• W2942262171 cites W2114032722 @default.
• W2942262171 cites W2115438934 @default.
• W2942262171 cites W2117007929 @default.
• W2942262171 cites W2120228185 @default.
• W2942262171 cites W2120717592 @default.
• W2942262171 cites W2121963790 @default.
• W2942262171 cites W2124773215 @default.
• W2942262171 cites W2135718381 @default.
• W2942262171 cites W2136913089 @default.
• W2942262171 cites W2142009991 @default.
• W2942262171 cites W2142791469 @default.
• W2942262171 cites W2147136418 @default.
• W2942262171 cites W2157638040 @default.
• W2942262171 cites W2169942381 @default.
• W2942262171 cites W2239460807 @default.
• W2942262171 cites W2319891554 @default.
• W2942262171 cites W2346240738 @default.
• W2942262171 cites W2397241490 @default.
• W2942262171 cites W2523075587 @default.
• W2942262171 cites W2586257300 @default.
• W2942262171 cites W2587295091 @default.
• W2942262171 cites W2736618702 @default.
• W2942262171 cites W2762721701 @default.
• W2942262171 cites W2767459647 @default.
• W2942262171 cites W2775781199 @default.
• W2942262171 cites W2779646623 @default.
• W2942262171 cites W2789142815 @default.
• W2942262171 cites W2887409185 @default.
• W2942262171 cites W2898955132 @default.
• W2942262171 cites W2918666868 @default.
• W2942262171 cites W4210627381 @default.
• W2942262171 doi "https://doi.org/10.1016/j.bmcl.2019.04.034" @default.
• W2942262171 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6531345" @default.
• W2942262171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31047750" @default.
• W2942262171 hasPublicationYear "2019" @default.
• W2942262171 type Work @default.
• W2942262171 sameAs 2942262171 @default.
• W2942262171 citedByCount "9" @default.
• W2942262171 countsByYear W29422621712020 @default.
• W2942262171 countsByYear W29422621712021 @default.
• W2942262171 countsByYear W29422621712022 @default.
• W2942262171 crossrefType "journal-article" @default.
• W2942262171 hasAuthorship W2942262171A5002042871 @default.
• W2942262171 hasAuthorship W2942262171A5020704398 @default.
• W2942262171 hasAuthorship W2942262171A5024562621 @default.
• W2942262171 hasAuthorship W2942262171A5036429812 @default.
• W2942262171 hasAuthorship W2942262171A5036871501 @default.
• W2942262171 hasAuthorship W2942262171A5038951690 @default.
• W2942262171 hasAuthorship W2942262171A5041727371 @default.
• W2942262171 hasAuthorship W2942262171A5057562012 @default.
• W2942262171 hasAuthorship W2942262171A5060147350 @default.
• W2942262171 hasAuthorship W2942262171A5074925440 @default.
• W2942262171 hasAuthorship W2942262171A5083715536 @default.
• W2942262171 hasAuthorship W2942262171A5084165762 @default.
• W2942262171 hasAuthorship W2942262171A5089233697 @default.
• W2942262171 hasBestOaLocation W29422621712 @default.

• next